New tests launched in January - Insights
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. Morice predicts top impacts on the diagnostic industry in 2024 - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first article, Dr. Morice reflects on the diagnostic landscape and predicts trends that could...
Medical Laboratory Professionals Week, also known as Lab Week, provides us with the opportunity to increase our understanding of and appreciation for clinical laboratory personnel. We celebrate their efforts to provide critical answers for...
Dr. Morice details how hospitals can maximize the value of their labs - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his latest article, he describes the untapped potential of hospital laboratories and how health...
CPT codes and LOINC update: April 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of April.
Lab Week Education Offerings - Insights
As we prepare to celebrate this year's Lab Week, the Mayo Collaborative Services Education team not only wants to highlight your important work as medical laboratory professionals and pathologists, but also help you feel more confident in...
Dr. Morice highlights the role of laboratories in promoting sustainability - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his latest article, he discusses sustainability in laboratories and the interconnectivity of...
The following resources can be used as a reminder for staff on the order of putting on and taking off, and reuse of PPE.
Hurricane Ian update - Insights
Due to hurricane Ian, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.